|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 205.30 PLN | 0.00% |
|
-5.74% | +33.38% |
| 07-17 | Bayer Ag and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials | CI |
| 07-17 | BAYER AG : JP Morgan keeps its Buy rating | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 54.48B | |||||
| 1,051B | |||||
| 609B | |||||
| 450B | |||||
| 330B | |||||
| 284B |
- Stock Market
- Stocks
- BAYN Stock
- BAY Stock
- Charts Bayer AG
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
